
억울한 환자들을 돕는 의사의 두 얼굴
Published October 22, 2026
At a glance
Views
520,379
Likes
7,594
Comments
191
Performance vs. channel
All-time outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
영화 [살인자리포트] 입니다 이 영상은 실제와 무관한 리뷰 형식으로 제작된 오락 콘텐츠입니다
- Published
- October 22, 2026
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.
How 억울한 환자들을 돕는 의사의 두 얼굴 is doing
It has 520K views in total. It ranks #7,237,489 among tracked YouTube videos by views.
Key facts about 억울한 환자들을 돕는 의사의 두 얼굴
- Total views
- 520K
- Total likes
- 7.59K
- Total comments
- 191
- Published
- October 22, 2026
- Global rank by views
- #7,237,489
Frequently asked questions
How many views does 억울한 환자들을 돕는 의사의 두 얼굴 have?
억울한 환자들을 돕는 의사의 두 얼굴 has 520,379 views, 7,594 likes and 191 comments, ranking #7,237,489 among tracked YouTube videos by views.
How accurate are these YouTube video analytics?
View, like, and comment counts come from YouTube's public API and refresh regularly. Growth and revenue figures are estimates built from tracked historical data, so they can differ slightly from what the creator sees privately in YouTube Studio.
What is the outlier score?
How this video's views compare to the channel's usual Shorts or long-form video. A 2x score means double the usual views for that channel, 0.5x means half.
What is engagement rate and how is it calculated?
Likes and comments per view, compared to this channel's typical engagement rate — shown as above or below what's usual for the channel.
How is the revenue estimate calculated?
It's a rough public estimate based on a $0.7–$2.0 CPM (revenue per 1,000 views) applied to view count — not actual creator earnings, which depend on ad rates, audience geography, and monetization settings YouTube doesn't expose publicly.
Is this YouTube video analytics checker free?
Yes. You get 10 free channel and video analytics lookups per 24 hours without an account — logging in, which is also free, removes that limit entirely.